2021 Vol.39, N°2 - Table of contents
March-April
One year in review
CER14665
2021,39,2
Pg. 0231-0241
Free to view
One year in review 2021: systemic lupus erythematosus
F. Trentin, D. Zucchi, V. Signorini, E. Elefante, A. Bortoluzzi, C. Tani
DOI: https://doi.org/10.55563/clinexprheumatol/7gzsxp
F. Trentin, D. Zucchi, V. Signorini, E. Elefante, A. Bortoluzzi, C. Tani
DOI: https://doi.org/10.55563/clinexprheumatol/7gzsxp
Full Papers
CER12141
2021,39,2
Pg. 0242-0252
Free to view
Change in MRI in patients with spondyloarthritis treated with anti-TNF agents: systematic review of the literature and meta-analysis
G. Khoury, B. Combe, J. Morel, C. Lukas
DOI: https://doi.org/10.55563/clinexprheumatol/fsluso
G. Khoury, B. Combe, J. Morel, C. Lukas
DOI: https://doi.org/10.55563/clinexprheumatol/fsluso
CER11775
2021,39,2
Pg. 0253-0262
Interleukin-7: a potential factor supporting B-cell maturation in the rheumatoid arthritis synovium
F. Ponchel, S. Churchman, J.J. El-Jawhari, A.N. Burska, P. Chambers, E.M. Vital, Y.M. El-Sherbiny, E. Jones, P.G. Conaghan, V. Goeb, P. Emery
DOI: https://doi.org/10.55563/clinexprheumatol/j6t7cj
F. Ponchel, S. Churchman, J.J. El-Jawhari, A.N. Burska, P. Chambers, E.M. Vital, Y.M. El-Sherbiny, E. Jones, P.G. Conaghan, V. Goeb, P. Emery
DOI: https://doi.org/10.55563/clinexprheumatol/j6t7cj
CER12908
2021,39,2
Pg. 0263-0268
Free to view
Impact of one-year treatment with biotechnological drugs on work ability in patients with rheumatoid arthritis in Italy: a prospective real-life study
M. Manara, R. Caporali, C. Lomater, R. Gorla, E. Fusaro, P. Sarzi-Puttini, P. Stobbione, S. Capri, L. Sinigaglia
DOI: https://doi.org/10.55563/clinexprheumatol/q69z52
M. Manara, R. Caporali, C. Lomater, R. Gorla, E. Fusaro, P. Sarzi-Puttini, P. Stobbione, S. Capri, L. Sinigaglia
DOI: https://doi.org/10.55563/clinexprheumatol/q69z52
CER13024
2021,39,2
Pg. 0269-0278
Free to view
Effectiveness and safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis: real-world data from the KOBIO Registry
J.H. Koh, S.-K. Lee, J. Kim, H.-A. Kim, K. Shin, J.-K. Min
DOI: https://doi.org/10.55563/clinexprheumatol/ftfgmf
J.H. Koh, S.-K. Lee, J. Kim, H.-A. Kim, K. Shin, J.-K. Min
DOI: https://doi.org/10.55563/clinexprheumatol/ftfgmf
CER13127
2021,39,2
Pg. 0279-0288
The onset of active disease in systemic lupus erythematosus patients is characterised by excessive regulatory CD4+-T-cell differentiation
M. Schaier, C. Gottschalk, F. Kälble, L. Uhlmann, V. Eckstein, C. Müller-Tidow, S. Meuer, K. Mahnke, H.-M. Lorenz, M. Zeier, A. Steinborn
DOI: https://doi.org/10.55563/clinexprheumatol/cg29xj
M. Schaier, C. Gottschalk, F. Kälble, L. Uhlmann, V. Eckstein, C. Müller-Tidow, S. Meuer, K. Mahnke, H.-M. Lorenz, M. Zeier, A. Steinborn
DOI: https://doi.org/10.55563/clinexprheumatol/cg29xj
CER13047
2021,39,2
Pg. 0289-0303
Iguratimod ameliorates rheumatoid arthritis progression through regulating miR-146a mediated IRAK1 expression and TRAF6/JNK1 pathway: an in vivo and in vitro study
R. Kong, J. Gao, L. Ji, Y. Peng, J. Zhang, D. Zhao
DOI: https://doi.org/10.55563/clinexprheumatol/urhbn0
R. Kong, J. Gao, L. Ji, Y. Peng, J. Zhang, D. Zhao
DOI: https://doi.org/10.55563/clinexprheumatol/urhbn0
CER13257
2021,39,2
Pg. 0304-0309
Associations between histogram analysis parameters derived from morphological sequences and histopathological tissue alterations in myositis and other myopathies: a preliminary study
H.-J. Meyer, I. Schneider, A. Emmer, M. Kornhuber, A. Surov
DOI: https://doi.org/10.55563/clinexprheumatol/a1cmel
H.-J. Meyer, I. Schneider, A. Emmer, M. Kornhuber, A. Surov
DOI: https://doi.org/10.55563/clinexprheumatol/a1cmel
CER13123
2021,39,2
Pg. 0310-0318
The mRNA levels of TGF-β Type II receptor splice variants in monocytes are associated with disease activity in patients with rheumatoid arthritis
A. Carrea, M.A. Preisegger, J. Velasco Zamora, R.A. Dewey
DOI: https://doi.org/10.55563/clinexprheumatol/ck1ksi
A. Carrea, M.A. Preisegger, J. Velasco Zamora, R.A. Dewey
DOI: https://doi.org/10.55563/clinexprheumatol/ck1ksi
CER12649
2021,39,2
Pg. 0319-0328
Free to view
ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritis
C. Specker, A. Alberding, M. Aringer, G.-R. Burmester, J.-P. Flacke, M.W. Hofmann, P. Kästner, H. Kellner, F. Moosig, M. Sieburg, H.-P. Tony, G. Fliedner
DOI: https://doi.org/10.55563/clinexprheumatol/3qdgi1
C. Specker, A. Alberding, M. Aringer, G.-R. Burmester, J.-P. Flacke, M.W. Hofmann, P. Kästner, H. Kellner, F. Moosig, M. Sieburg, H.-P. Tony, G. Fliedner
DOI: https://doi.org/10.55563/clinexprheumatol/3qdgi1
CER13036
2021,39,2
Pg. 0329-0336
Free to view
Rapid and sustained improvements in patient-reported signs and symptoms with ixekizumab in biologic-naive and TNF-inadequate responder patients with psoriatic arthritis
A.-M. Orbai, D.D. Gladman, H. Goto, J.A. Birt, A.M. Gellett, C.-Y. Lin, T.K. Kvien
DOI: https://doi.org/10.55563/clinexprheumatol/c2lbri
A.-M. Orbai, D.D. Gladman, H. Goto, J.A. Birt, A.M. Gellett, C.-Y. Lin, T.K. Kvien
DOI: https://doi.org/10.55563/clinexprheumatol/c2lbri
CER13142
2021,39,2
Pg. 0337-0343
Free to view
The ovarian reserve as measured by the anti-Müllerian hormone is not diminished in patients with rheumatoid arthritis compared to the healthy population
M. Lopez-Corbeto, S. Martínez-Mateu, A. Pluma, R. Ferrer, M. López-Lasanta, J.J. De Agustín, M. Barceló, A. Julià, S. Marsal
DOI: https://doi.org/10.55563/clinexprheumatol/73txen
M. Lopez-Corbeto, S. Martínez-Mateu, A. Pluma, R. Ferrer, M. López-Lasanta, J.J. De Agustín, M. Barceló, A. Julià, S. Marsal
DOI: https://doi.org/10.55563/clinexprheumatol/73txen
CER13185
2021,39,2
Pg. 0344-0350
Relationship between common carotid distensibility/aortic stiffness and cardiac left ventricular morphology and function in a group of patients affected by chronic rheumatic diseases: an observational study
A. Dalbeni, A. Giollo, F. Cattazzo, M. Bevilacqua, A. Mantovani, A. Tagetti, G. Orsolini, G. Cioffi, F. Ognibeni, P. Minuz, M. Rossini, O. Viapiana, C. Fava
DOI: https://doi.org/10.55563/clinexprheumatol/ep635g
A. Dalbeni, A. Giollo, F. Cattazzo, M. Bevilacqua, A. Mantovani, A. Tagetti, G. Orsolini, G. Cioffi, F. Ognibeni, P. Minuz, M. Rossini, O. Viapiana, C. Fava
DOI: https://doi.org/10.55563/clinexprheumatol/ep635g
CER13081
2021,39,2
Pg. 0351-0356
Accumulation of autophagosome cargo protein p62 is common in idiopathic inflammatory myopathies
J.C. Milisenda, I. Pinal-Fernandez, T.E. Lloyd, J.M. Grau, F.W. Miller, A. Selva-O'callaghan, L. Christopher-Stine, W. Stenzel, A.L. Mammen, A.M. Corse
DOI: https://doi.org/10.55563/clinexprheumatol/6mp37n
J.C. Milisenda, I. Pinal-Fernandez, T.E. Lloyd, J.M. Grau, F.W. Miller, A. Selva-O'callaghan, L. Christopher-Stine, W. Stenzel, A.L. Mammen, A.M. Corse
DOI: https://doi.org/10.55563/clinexprheumatol/6mp37n
CER12921
2021,39,2
Pg. 0357-0364
Social economic costs of ankylosing spondylitis in Spain
M. Merino, O. Braçe, A. González-Domínguez, Á. Hidalgo-Vega, M. Garrido-Cumbrera, J. Gratacós
DOI: https://doi.org/10.55563/clinexprheumatol/lycdc8
M. Merino, O. Braçe, A. González-Domínguez, Á. Hidalgo-Vega, M. Garrido-Cumbrera, J. Gratacós
DOI: https://doi.org/10.55563/clinexprheumatol/lycdc8
CER12824
2021,39,2
Pg. 0365-0371
Free to view
BENEFIT: real-world effectiveness of SB4 after transition from reference etanercept in rheumatoid arthritis and axial spondyloarthritis
C. Selmi, K. Krüger, A. Cantagrel, M.A. Abad Hernández, U. Freudensprung, M. Farouk Rezk, J. Addison
DOI: https://doi.org/10.55563/clinexprheumatol/usrd9z
C. Selmi, K. Krüger, A. Cantagrel, M.A. Abad Hernández, U. Freudensprung, M. Farouk Rezk, J. Addison
DOI: https://doi.org/10.55563/clinexprheumatol/usrd9z
CER13248
2021,39,2
Pg. 0372-0377
Severely destructive unilateral wrist arthritis as a rare variant of rheumatoid arthritis: analysis of clinical and imaging features
V. Korendovych, J. Fleischhammer, B. Tampe, E. Nikiphorou, R. Vasko, G.A. Müller, P. Korsten
DOI: https://doi.org/10.55563/clinexprheumatol/ke6i5b
V. Korendovych, J. Fleischhammer, B. Tampe, E. Nikiphorou, R. Vasko, G.A. Müller, P. Korsten
DOI: https://doi.org/10.55563/clinexprheumatol/ke6i5b
CER13202
2021,39,2
Pg. 0378-0384
Free to view
Interleukin 17E associates with haematologic involvement and autoantibody production in primary Sjögren’s syndrome
X. Zhao, Y. Gan, Y. Jin, J. He, R. Jia, Y. Li, H. Luan, H. Ye, Q. Wang, Y. Liu, D. Shen, X. Sun, Z. Li
DOI: https://doi.org/10.55563/clinexprheumatol/gbjatf
X. Zhao, Y. Gan, Y. Jin, J. He, R. Jia, Y. Li, H. Luan, H. Ye, Q. Wang, Y. Liu, D. Shen, X. Sun, Z. Li
DOI: https://doi.org/10.55563/clinexprheumatol/gbjatf
CER13181
2021,39,2
Pg. 0385-0392
Anti-tumour necrosis factor-alpha response associated with combined CD226 and HLA-DRB1[*]0404 haplotype in rheumatoid arthritis
D.S. Gibson, C.M. Mcgeough, S. Watterson, J. Blayney, G.D. Wright, A. Pendleton, P. Gardiner, D. Small, A.J. Eakin, T. Ahmed, H.A. Murray, M.J. Latten, M.A. Crockard, J.V. Lamont, S.-D. Zhang, A.J. Bjourson
DOI: https://doi.org/10.55563/clinexprheumatol/u1mi30
D.S. Gibson, C.M. Mcgeough, S. Watterson, J. Blayney, G.D. Wright, A. Pendleton, P. Gardiner, D. Small, A.J. Eakin, T. Ahmed, H.A. Murray, M.J. Latten, M.A. Crockard, J.V. Lamont, S.-D. Zhang, A.J. Bjourson
DOI: https://doi.org/10.55563/clinexprheumatol/u1mi30
CER12902
2021,39,2
Pg. 0393-0402
Assessing serum IgG4 glycosylation profiles of IgG4-related disease using lectin microarray
C. Hu, P. Zhang, L. Li, C. Liu, J. Li, W. Zhang, Y. Li
DOI: https://doi.org/10.55563/clinexprheumatol/2i3uvr
C. Hu, P. Zhang, L. Li, C. Liu, J. Li, W. Zhang, Y. Li
DOI: https://doi.org/10.55563/clinexprheumatol/2i3uvr
Brief Paper
CER13963
2021,39,2
Pg. 0403-0406
Free to view
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial
P. Ruscitti, O. Berardicurti, P. Cipriani, R. Giacomelli
on behalf of the TRACK study group
DOI: https://doi.org/10.55563/clinexprheumatol/phsqg7
P. Ruscitti, O. Berardicurti, P. Cipriani, R. Giacomelli
on behalf of the TRACK study group
DOI: https://doi.org/10.55563/clinexprheumatol/phsqg7
Reviews
CER13041
2021,39,2
Pg. 0407-0412
Free to view
Guidelines on prescribing and monitoring antimalarials in rheumatic diseases: a systematic review
G. Cramarossa, H.-Y. Liu, M.A. Turk, J.E. Pope
DOI: https://doi.org/10.55563/clinexprheumatol/1u36qt
G. Cramarossa, H.-Y. Liu, M.A. Turk, J.E. Pope
DOI: https://doi.org/10.55563/clinexprheumatol/1u36qt
CER13348
2021,39,2
Pg. 0413-0421
Free to view
New developments in ultrasound in rheumatology: innovative tools and promising applications
G. Sakellariou, I. Giovannini, S. Grignaschi, A. Zabotti, A. Iagnocco
DOI: https://doi.org/10.55563/clinexprheumatol/5tf1kq
G. Sakellariou, I. Giovannini, S. Grignaschi, A. Zabotti, A. Iagnocco
DOI: https://doi.org/10.55563/clinexprheumatol/5tf1kq
CER13544
2021,39,2
Pg. 0422-0425
Free to view
Fibromyalgia in women: somatisation or stress-evoked, sex-dimorphic neuropathic pain?
M. Martínez-Lavín
DOI: https://doi.org/10.55563/clinexprheumatol/0c7d6v
M. Martínez-Lavín
DOI: https://doi.org/10.55563/clinexprheumatol/0c7d6v
Paediatric Rheumatology
CER13449
2021,39,2
Pg. 0426-0433
Free to view
Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis
C. Bava, F. Mongelli, A. Pistorio, M. Bertamino, G. Bracciolini, S. Dalprà, S. Davì, S. Lanni, V. Muratore, S. Pederzoli, S. Rosina, B. Schiappapietra, C. Suffia, G.C. Varnier, S. Verazza, G. Giancane, A. Consolaro, A. Ravelli
DOI: https://doi.org/10.55563/clinexprheumatol/rxidz4
C. Bava, F. Mongelli, A. Pistorio, M. Bertamino, G. Bracciolini, S. Dalprà, S. Davì, S. Lanni, V. Muratore, S. Pederzoli, S. Rosina, B. Schiappapietra, C. Suffia, G.C. Varnier, S. Verazza, G. Giancane, A. Consolaro, A. Ravelli
DOI: https://doi.org/10.55563/clinexprheumatol/rxidz4
Letters to the Editor
CER12696
2021,39,2
Pg. 0434
Free to view
Malignancies in Chinese patients with immunoglobulin G4-related disease
Z. Yang, Z. Hu
DOI: https://doi.org/10.55563/clinexprheumatol/js8u0a
Z. Yang, Z. Hu
DOI: https://doi.org/10.55563/clinexprheumatol/js8u0a
CER12945
2021,39,2
Pg. 0435-0436
Free to view
High prevalence of ultrasound-defined enthesitis in patients with metabolic syndrome.
Comment on: How normal is the enthesis by ultrasound in healthy subjects? Di Matteo et al.
P. Falsetti, E. Conticini, C. Baldi, C. Acciai, B. Frediani
DOI: https://doi.org/10.55563/clinexprheumatol/zm9e6u
P. Falsetti, E. Conticini, C. Baldi, C. Acciai, B. Frediani
DOI: https://doi.org/10.55563/clinexprheumatol/zm9e6u
CER13034
2021,39,2
Pg. 0437
Free to view
Reply to: High prevalence of ultrasound-defined enthesitis in patients with metabolic syndrome
A. Di Matteo, E. Filippucci, E. Cipolletta, W. Grassi
DOI: https://doi.org/10.55563/clinexprheumatol/fk5e1e
A. Di Matteo, E. Filippucci, E. Cipolletta, W. Grassi
DOI: https://doi.org/10.55563/clinexprheumatol/fk5e1e
CER13644
2021,39,2
Pg. 0438
Free to view
A prosthetic wrist joint complicated by metallosis and polyethylene synovitis, mimicking low-grade bacterial arthritis
J.W. Jacobs, A.H. Schuurman
DOI: https://doi.org/10.55563/clinexprheumatol/mxhrig
J.W. Jacobs, A.H. Schuurman
DOI: https://doi.org/10.55563/clinexprheumatol/mxhrig
CER13929
2021,39,2
Pg. 0439
Free to view
Unusual ossification: psoriatic arthritis or not?
R. Ramonda, S. Vio, A. Ortolan, M. Lorenzin
DOI: https://doi.org/10.55563/clinexprheumatol/m2qah9
R. Ramonda, S. Vio, A. Ortolan, M. Lorenzin
DOI: https://doi.org/10.55563/clinexprheumatol/m2qah9
CER13721
2021,39,2
Pg. 0440
Free to view
Biosimilars and retention rates in patients with ankylosing spondylitis
E. Pelechas, E. Kaltsonoudis, P.V. Voulgari, A.A. Drosos
DOI: https://doi.org/10.55563/clinexprheumatol/4cualr
E. Pelechas, E. Kaltsonoudis, P.V. Voulgari, A.A. Drosos
DOI: https://doi.org/10.55563/clinexprheumatol/4cualr
CER13925
2021,39,2
Pg. 0441
Free to view
Polymyalgia rheumatica without elevated baseline acute phase reactants
C. Manzo, M. Milchert, M. Natale, M. Brzosko
DOI: https://doi.org/10.55563/clinexprheumatol/s4c5k3
C. Manzo, M. Milchert, M. Natale, M. Brzosko
DOI: https://doi.org/10.55563/clinexprheumatol/s4c5k3
CER13669
2021,39,2
Pg. 0442-0443
Free to view
Epidemiology and clinical characteristics of COVID-19 in rheumatic diseases at a tertiary care hospital in Wuhan, China
M. Chen, Y. Wei, Q. Zhang, Q. Wan, X. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/13xbku
M. Chen, Y. Wei, Q. Zhang, Q. Wan, X. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/13xbku